AHR and neoplasm: Trabanelli et al. (2014) proved that IDO2 stimulation induces the generation of Tregs due to AhR activation. In addition, Liu et al. (2020) hypothesized that by using siRNA technology to silence IDO2 in DCs would activate them to enhance the anti-tumor response and suppress tumor progression.